I’ll leave you with a couple snippets from our “firm-wide trading log.” As you’ll note, in our view, even though the foreseeable future looks anything but bright from our present vantage point, there will absolutely be opportunities to exploit, as well as risks to manage:

Note: Feel free to shoot me an email if you’d like translations of any unfamiliar terms…

10/16/2020 HEDGING ACTIVITY 
We added what amounts to a third of the number of current put hedge contracts in 11/13 3000-strike spx puts (or xsp equivalents). This firms up the hedge a bit (has lost some potency given OTM-ness and theta) in case of an immediately-bearish election outcome… We also bought 12/31 4000-strike calls (“) to provide some upside on bullish election and/or positive vaccine news. On average the addition amounted to a cost less than 0.20% of each client’s portfolio.

10/22/2020 (amended 10/26) POTENTIAL ALLOCATION TWEAKS
Europe is a mess with regard to covid; adding notable stress to an already severely stressed economy, and its markets reflect it. A vaccine and effective therapies will no doubt offer hope to equity investors, plus a positive Brexit outcome (which I expect) will help as well. Asia, on the other hand, is having a better go of it on covid, and, if we can believe China’s numbers (we should be skeptical) in particular (although South Korea is also showing promise), economic conditions are better as well.

Question being, which area of the developed world offers the best prospects going forward? While Europe is working off a lower base, in terms of equity price action in 2020, Asia has a somewhat better overall setup right here. Considering reducing our FEZ exposure and picking up a bit more VPL with the proceeds… Will look at country ETFs in the region as well.

Also, emerging market equities are interesting right here. Our general thesis says that the dollar will trend lower for the foreseeable future, in which case emerging market equities are an obvious play. Considering upping exposure there as well, taking from the cash allocation. 

In terms of U.S. sectors, energy remains severely off of its pre-covid high. A pickup in activity and/or inflation will likely see the sectors’ equities higher. Valuation is relatively compelling… Considering upping the target allocation at the margin (a great deal of macro risk remains in the system, however), question being, do we go all xle or do we include an individual position, such as Schlumberger?

Commodities are also an obvious play relative to our thesis, one that we’ll likely increase in the months to come. In the very near-term, however, I expect a potentially dollar-driven pullback that would offer up a better entry for adding exposure. In that event we’d reduce our cash exposure to gain it.

With regard to potential adjustments (the above just scratching the surface [I’ve previously mentioned our intent to exploit infrastructure opportunities next year, for example]), each is unique in and of itself. Cutting European equity exposure, for example, demands that we cover all conceivable angles. I.e., the ECB (European Central Bank) meets tomorrow, and, as I mentioned in the note, a Brexit trade deal is pending, and there’s likely a vaccine in our near future. Bullish outcomes here could see a period of global outperformance for this severely beaten down region of the world. Thus, any near-term adjustment we make will likely be modest. Longer-term, however, we may find ourselves owning notably more Asia and less Europe… 

Bottom line: Global markets are dynamic, and, therefore, so is our analysis. Intimacy with global macro conditions, painstaking diligence, open-mindedness, humility and proper risk management are all essential to doing it right over the long-term.